articleThe LancetApr 9, 2020BRONZE OA

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

MFMarc FeldmannRNRavinder N. MainiJNJames N. WoodySTStephen T. HolgateGWGregory Winter

University of Oxford · Nuffield Orthopaedic Centre · +6 more institutions

PubMed
Indexed incrossrefdatacitepubmed

Abstract

No abstract available for this paper.

Citation impact

552
total citations
FWCI
13.47
Percentile
100%
References
31
Citations per year

Authors

8

Topics & keywords

Topics
Keywords
  • Coronavirus disease 2019 (COVID-19)
  • 2019-20 coronavirus outbreak
  • Medicine
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Intensive care medicine
  • Virology
  • Internal medicine
  • Outbreak
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding